STS Medical
2013
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$450K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of a composite removable sinus stent. The company's temporary, natural nasal stent is inserted after endoscopic surgery for the treatment of chronic sinusitus. The stent keeps the sinus cavity open up to 28 days after surgery, long enough for the sinus tissue to heal which decreases the likelihood of revision surgery and improves patient outcomes.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
- Misgav Business Park
- 17 Tchelet Street
- M.P. Misgav 2017400
- Israel
+972 000-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore STS Medical’s full profile, request a free trial.
STS Medical Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 28-Apr-2015 | $450K | 00000 | Completed | Pre-Clinical Trials | |
| 2. Early Stage VC | 01-Nov-2013 | 00000 | 00000 | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Nov-2013 | $707K | Completed | Pre-Clinical Trials |
STS Medical Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| The Trendlines Group | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
STS Medical Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Joseph Flomenblit Ph.D | Chief Executive Officer and Founder |
STS Medical Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Zeev Bronfeld | The Trendlines Group | Chairman | 000 0000 |